Author

Barbara Jasińska‐Myga

Observed names: B Jasińska-Myga, B. Jasinska‐Myga, B. Jasińska-Myga, Barbara Jasinska Myga, Barbara Jasinska-Myga, Barbara Jasinska-myga, Barbara Jasinska‐Myga, Barbara Jasińska-Myga, Barbara Myga, Barbara Myga Jasińska, Jasinska-Myga Barbara, Jasinska-Myga, Barbara, Jasińska-Myga, Barbara; Katedra i Klinika Neurologii Wieku Podeszłego Śląskiej Akademii Medycznej w Katowicach

Institution: Medical University of Silesia

Observed institutions: Mayo Clinic, Medical University of Silesia, German Center for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, Mayo Clinic in Florida, Gdańsk Medical University, University of Tübingen, Stanford University

OpenAlex ID: A5016429635

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study

2011 · Owen A Ross, Alexandra I Soto-Ortolaza, et al. · The Lancet Neurology · 336

PDF

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

2017 · Davina J Hensman Moss, Antonio F Pardiñas, et al. · The Lancet Neurology · 311

PDF

Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research

2012 · Selina Wray, Matthew Self, et al. · PLoS ONE · 138

PDF

Large-scale replication and heterogeneity in Parkinson disease genetic loci

2012 · Manu Sharma, John P.A. Ioannidis, et al. · Neurology · 131

PDF

LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease

2010 · Carles Vilariño-Güell, Christian Wider, et al. · Neurogenetics · 128

PDF

A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants

2012 · Manu Sharma, John P A Ioannidis, et al. · Journal of Medical Genetics · 107

PDF

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease

2010 · Alexis Elbaz, Owen A. Ross, et al. · Annals of Neurology · 90

Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease

2013 · Dorota Hoffman-Zacharska, Dariusz Koziorowski, et al. · Parkinsonism & Related Disorders · 88

LINGO1 rs9652490 is associated with essential tremor and Parkinson disease

2009 · Carles Vilariño-Güell, Owen A. Ross, et al. · Parkinsonism & Related Disorders · 75

A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease

2009 · Rejko Krüger, Manu Sharma, et al. · Neurobiology of Aging · 73

Association of α-, β-, and γ-Synuclein With Diffuse Lewy Body Disease

2010 · Kenya Nishioka, Christian Wider, et al. · Archives of Neurology · 71

PDF

Association of the MAPT locus with Parkinson’s disease

2009 · C. Wider, C. Vilariño‐Güell, et al. · European Journal of Neurology · 61

Early-onset Parkinson's disease due to PINK1 p.Q456X mutation – Clinical and functional study

2014 · Joanna Siuda, Barbara Jasinska-Myga, et al. · Parkinsonism & Related Disorders · 58

Apolipoprotein E Gene Polymorphism, Total Plasma Cholesterol Level, and Parkinson Disease Dementia

2007 · Barbara Jasinska-Myga, Grzegorz Opala, et al. · Archives of Neurology · 56

Clinical manifestations of intermediate allele carriers in Huntington disease

2016 · Esther Cubo, María A. Ramos-Arroyo, et al. · Neurology · 53

An evaluation of the impact ofMAPT,SNCAandAPOEon the burden of Alzheimer's and Lewy body pathology

2012 · Christian Wider, Owen A Ross, et al. · Journal of Neurology Neurosurgery & Psychiatry · 52

Evaluation of gastric emptying in familial and sporadic Parkinson disease

2009 · Anna Krygowska-Wajs, William P. Cheshire, et al. · Parkinsonism & Related Disorders · 45

Loss of ability to work and ability to live independently in Parkinson’s disease

2011 · Barbara Jasinska-Myga, Michael G. Heckman, et al. · Parkinsonism & Related Disorders · 41

PDF

Human leukocyte antigen variation and Parkinson’s disease

2011 · Andreas Puschmann, Christophe Verbeeck, et al. · Parkinsonism & Related Disorders · 41

The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants

2013 · Michael G. Heckman, Alexis Elbaz, et al. · Neurobiology of Aging · 40

PDF

Population‐specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortium

2013 · Michael G. Heckman, Alexandra I. Soto‐Ortolaza, et al. · Movement Disorders · 38

PDF

Reduced Cancer Incidence in Huntington’s Disease: Analysis in the Registry Study

2018 · Paul McNulty, Richard Pilcher, et al. · Journal of Huntington s Disease · 35

Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease

2011 · Manu Sharma, Demetrius M. Maraganore, et al. · Neurobiology of Aging · 34

Depression in Parkinson's Disease

2010 · Barbara Jasinska-Myga, John D. Putzke, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 33

PDF

From mild cognitive impairment to Alzheimer's disease - influence of homocysteine, vitamin B12 and folate on cognition over time: results from one-year follow-up.

2009 · Joanna Siuda, Agnieszka Gorzkowska, et al. · PubMed · 31

Works count: 64

Citation count: 2,571

H-index: 28

I10-index: 39